Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03068
Species: Mus musculus
Position : chr1:172411511-172413110
Year: 2021
Title: ATAC-Seq Reveals an Isl1 Enhancer That Regulates Sinoatrial Node Development and Function
Genome Build: mm10
Enhancer Type: Enhancer
Condition: Normal
Disease Name: --
PMID:  33044128
MONDO:
Tissue: Heart
Tissue Ontology ID: UBERON:0000948
Cell Source: Not available
CVCL ID:
Cell Type: cardiomyocyte
Cell Ontology ID: CL:0000746
Experiment Type: Enhancer activity assay
High Throughput Method: ATAC-seq, RNA-seq, ChIP-seq
Low Throughput Method: Transgenic Reporter Assay, X-gal Staining
About Target Gene
Target gene : Rgs6
About TF
TF name : Mef2C
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Mef2C CDO in myogenesis reactome 29
Mef2C Circadian Clock reactome 49
Mef2C ErbB1 downstream signaling pid 105
Mef2C ERK/MAPK targets reactome 17
Mef2C Notch netpath 76
Mef2C Oxidative stress response panther 23
Mef2C p38 MAPK pathway panther 31
Mef2C Regulation of nuclear SMAD2/3 signaling pid 82
Mef2C Regulation of retinoblastoma protein pid 67
Mef2C Signaling events mediated by HDAC Class II pid 58
Mef2C Signaling mediated by p38-alpha and p38-beta pid 35
Mef2C TGF_beta_Receptor netpath 220
Mef2C Transcriptional activation of mitochondrial biogenesis reactome 43
Mef2C Trk receptor signaling mediated by the MAPK pathway pid 34
Mef2C MAPK signaling pathway kegg 264
Mef2C Hs_Endochondral_Ossification_WP474_87977 wikipathways 43
Mef2C Hs_VEGFA-VEGFR2_Signaling_Pathway_WP3888_90000 wikipathways 153
Mef2C Hs_Heart_Development_WP1591_90186 wikipathways 28
Mef2C Hs_Oxidation_by_Cytochrome_P450_WP43_84102 wikipathways 14
Mef2C Hs_TGF-beta_Signaling_Pathway_WP366_90028 wikipathways 67
Enhancer Associated Network
Overlapping Enhancers (mm10) 1 found
Enhancer ID Position Tissue Cell Disease
E_02329 chr1:172411511-172413110 Heart sinoatrial node pacemaker cell --
Expression of Target Genes for the Enhancer